Further clinical trials on macrolides for bronchiolitis in infants are unnecessary - 06/10/15
Doi : 10.1016/j.jaci.2015.07.012
Gabrielle B. McCallum, BNursing, MPH, PhD a 
, Anne B. Chang, MBBS, FRACP, PhD a, b, Keith Grimwood, MB, ChB, FRACP, MD c
, Anne B. Chang, MBBS, FRACP, PhD a, b, Keith Grimwood, MB, ChB, FRACP, MD c a Menzies School of Health Research, Charles Darwin University, Casuarina, Australia
b Queensland Children's Medical Research Institute, Children's Health Queensland, Queensland University of Technology, Brisbane, Australia
c Griffith University and Gold Coast University Hospital, Southport, Australia
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: G. B. McCallum has received research support from the National Health and Medical Research Council (Australia) and Financial Markets Foundation of Children. A. B. Chang has received research support from the National Health and Medical Research Council (Australia), Financial Markets Foundation of Children, and GlaxoSmithKline and has received travel support from Johnson & Johnson, China. K. Grimwood has received research support from the National Health and Medical Research Council (Australia) and is on the GlaxoSmithKline Advisory Board on pneumococcal conjugate vaccines. |
© 2015
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 136 - N° 4
P. 1134-1135 - octobre 2015 Retour au numéro
Article précédent
- Inhibition of eosinophil apoptosis by asthma-relevant cytokines from platelets
- Venkatramanan Varadharajan
- Reply
- Avraham Beigelman, Leonard B. Bacharier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?